While they don’t discount forward-looking uncertainties, a pair of top shelf US macroeconomic indicators point to greater than expected strength in the US economy as it transitioned from Q1 into Q2. The US consumer and industrial conditions indicate rather vibrant conditions.


US retail sales, m/m % change, April, headline / ex-autos / ex-autos&gas / control group:
Actual: 0.9 / 0.6 / 1.0 / 1.0
Scotia: 1.0 / 0.0 / na / na
Consensus: 1.0 / 0.4 / 0.7 / 0.7
Prior: 1.4 / 2.1 / 1.2 / 1.1 (revised up from 0.5 / 1.1 / 0.2 / -0.1)

Attention any forecasters tempted to write-off the US consumer in 2022: with the helping hand of annual revisions plus added momentum, they’rrreeee baaaaccckkk! It turns out that the soft patch was just a statistical mirage. Go here for the full release. Chart 1 shows that the pandemic has been left in the dust. Strong jobs, high cash balances, solid wage gains, high home equity and pent-up demand for services and some durables plus perhaps slowly easing supply side constraints are the upsides you don’t hear as much about compared to the impact of higher borrowing costs.

Prior revisions played a major role in saving the day. That’s not uncommon with this report. Check out chart 2 that shows monthly revisions to m/m changes in core retail sales (ex-autos and gas) over time and how they can be massive in both directions. There is a slight bias toward positive revisions over time (56% of the revisions since 2009). This time around the culprit was advance annual retail sales revisions.

Even on the back of those revisions the numbers were still stronger than expected. Headline sales roughly met expectations (+0.9% m/m, consensus 1%) but core sales ex-autos and gas were up by 1% (consensus 0.7%). This translates into a solid real gain given that CPI was up 0.3% m/m and core CPI was up 0.6% during April.

Key is the retail sales control group which is how this gets factored into consumption within GDP. The RSCG was up by 1% m/m and revised up from -0.1% m/m in March to +1.1% m/m. Presto, what weakness!!

Furthermore, what the upward revisions do is to remove an inflation-adjusted (real) decline in March and indicate that real sales were instead roughly flat in terms of headline but up pretty strongly in terms of real core sales

US nominal retail sales were up 14.4% q/q SAAR in Q1 (chart 3). They are tracking a further 10% q/q SAAR gain in Q2 based only on April and the Q1 avg while assuming May and June are flat in order to focus the math upon what we know so far.

These are huge numbers and remember that retail sales don't capture most of the services spending that has been recovering post-omicron.

Chart 4 breaks down the retail sales gain in April by category. Chart 5 does this on a weighted contribution basis to show which categories played the biggest weighted roles in driving total retail sales higher. Chart 6 shows the cumulative recovery in retail sales by category to show that all are now posting higher sales than before the pandemic in nominal terms, although the bottom categories would still be lower in real terms.


US industrial production, April, m/m % change SA:
Actual: 1.1
Scotia: 0.2
Consensus: 0.5
Prior: 0.9

US industrial output was up by 1.1% m/m in April (consensus 0.5%). ISM-manufacturing’s production subindex was a head fake in signalling slower output growth.

In fact, manufacturing output was up by 0.8% m/m in April, matching March's gain after February's 1.3% m/m rise. US industrial output accelerated over the past three months compared to the prior three months.

Mining output was up by 1.6% m/m. Utilities output was up 2.4% m/m.

There was high breadth across components (consumer goods, business equipment, construction, materials etc). Chart 7 provides the more detailed breakdown of which sectors drove higher industrial output last month with mining, utilities and autos the three leaders.

Given that producer prices were up by 0.5% m/m in April with PPI ex-food and energy up 0.4%, the industrial output gains generally outpaced inflation and therefore signal higher volumes of activity.

Capacity utilization climbed to 79% which is the highest since December 2018 and only 0.9 ppts below the pre-pandemic peak in August 2018 (Chart 8).

US industrial output was up 7.7% q/q SAAR in Q1 and is tracking another 8.1% q/q rise in Q2.


This report has been prepared by Scotiabank Economics as a resource for the clients of Scotiabank. Opinions, estimates and projections contained herein are our own as of the date hereof and are subject to change without notice. The information and opinions contained herein have been compiled or arrived at from sources believed reliable but no representation or warranty, express or implied, is made as to their accuracy or completeness. Neither Scotiabank nor any of its officers, directors, partners, employees or affiliates accepts any liability whatsoever for any direct or consequential loss arising from any use of this report or its contents.

These reports are provided to you for informational purposes only. This report is not, and is not constructed as, an offer to sell or solicitation of any offer to buy any financial instrument, nor shall this report be construed as an opinion as to whether you should enter into any swap or trading strategy involving a swap or any other transaction. The information contained in this report is not intended to be, and does not constitute, a recommendation of a swap or trading strategy involving a swap within the meaning of U.S. Commodity Futures Trading Commission Regulation 23.434 and Appendix A thereto. This material is not intended to be individually tailored to your needs or characteristics and should not be viewed as a “call to action” or suggestion that you enter into a swap or trading strategy involving a swap or any other transaction. Scotiabank may engage in transactions in a manner inconsistent with the views discussed this report and may have positions, or be in the process of acquiring or disposing of positions, referred to in this report.

Scotiabank, its affiliates and any of their respective officers, directors and employees may from time to time take positions in currencies, act as managers, co-managers or underwriters of a public offering or act as principals or agents, deal in, own or act as market makers or advisors, brokers or commercial and/or investment bankers in relation to securities or related derivatives. As a result of these actions, Scotiabank may receive remuneration. All Scotiabank products and services are subject to the terms of applicable agreements and local regulations. Officers, directors and employees of Scotiabank and its affiliates may serve as directors of corporations.

Any securities discussed in this report may not be suitable for all investors. Scotiabank recommends that investors independently evaluate any issuer and security discussed in this report, and consult with any advisors they deem necessary prior to making any investment.

This report and all information, opinions and conclusions contained in it are protected by copyright. This information may not be reproduced without the prior express written consent of Scotiabank.

™ Trademark of The Bank of Nova Scotia. Used under license, where applicable.

Scotiabank, together with “Global Banking and Markets”, is a marketing name for the global corporate and investment banking and capital markets businesses of The Bank of Nova Scotia and certain of its affiliates in the countries where they operate, including; Scotiabank Europe plc; Scotiabank (Ireland) Designated Activity Company; Scotiabank Inverlat S.A., Institución de Banca Múltiple, Grupo Financiero Scotiabank Inverlat, Scotia Inverlat Casa de Bolsa, S.A. de C.V., Grupo Financiero Scotiabank Inverlat, Scotia Inverlat Derivados S.A. de C.V. – all members of the Scotiabank group and authorized users of the Scotiabank mark. The Bank of Nova Scotia is incorporated in Canada with limited liability and is authorised and regulated by the Office of the Superintendent of Financial Institutions Canada. The Bank of Nova Scotia is authorized by the UK Prudential Regulation Authority and is subject to regulation by the UK Financial Conduct Authority and limited regulation by the UK Prudential Regulation Authority. Details about the extent of The Bank of Nova Scotia's regulation by the UK Prudential Regulation Authority are available from us on request. Scotiabank Europe plc is authorized by the UK Prudential Regulation Authority and regulated by the UK Financial Conduct Authority and the UK Prudential Regulation Authority.

Scotiabank Inverlat, S.A., Scotia Inverlat Casa de Bolsa, S.A. de C.V, Grupo Financiero Scotiabank Inverlat, and Scotia Inverlat Derivados, S.A. de C.V., are each authorized and regulated by the Mexican financial authorities.

Not all products and services are offered in all jurisdictions. Services described are available in jurisdictions where permitted by law.